Seeking to enable researchers and clinicians to share experiences and ideas regarding a relatively rare—and, so far, incurable—condition, the National Institutes of Health (NIH) sponsored its first international meeting on pulmonary arterial hypertension.
The December gathering in Bethesda, Md, was designed to be “a forum for learning, scientific discussion, and development of new collaborations that will further the understanding of pulmonary hypertension and hopefully lead to treatment advances for the disease,” said Roberto Machado, MD, an investigator with the Vascular Medicine Branch of the NIH's National Heart, Lung, and Blood Institute (NHLBI).
Mitka M. Researchers Explore Rare Lung Disorder. JAMA. 2007;297(5):456-457. doi:10.1001/jama.297.5.456